Aim: This study investigated the value of regional cerebral oxygen saturation (rSO 2 ) monitoring upon arrival at the hospital for predicting post-cardiac arrest intervention outcomes. Methods: We enrolled 1195 patients with out-of-hospital cardiac arrest of presumed cardiac cause from the Japan-Prediction of Neurological Outcomes in Patients Post-cardiac Arrest Registry. The primary endpoint was a good neurologic outcome (cerebral performance categories 1 or 2 [CPC1/2]) 90 days post-event.
Introduction
The advent of systematic bundled post-cardiac arrest interventions (PCAI) has increased the likelihood of patients surviving with good neurologic function after out-of-hospital cardiac arrests (OHCA). 1, 2 In particular, therapeutic hypothermia (TH) and percutaneous coronary intervention (PCI) with emergent coronary angiography (CAG) have been reported to improve the prognoses of patients following OHCA of presumed cardiac cause. [2] [3] [4] On the other hand, recent studies have shown that TH does not provide a beneficial effect following OHCA. 5, 6 In fact, brain damage severity estimations and outcome prognoses for OHCA patients were found to be inaccurate, 7, 8 implying that stratification before or imbalance corrections after randomisation might have been problematic in many previous studies. Additionally, the absence of appropriate measurements for brain damage severity estimations and prognosis determinations might make it difficult to perform stratified randomisations in clinical trials involving patients experiencing OHCA of presumed cardiac cause. 9 Thus, better prognostic factors are needed to elucidate 'true indications' of PCAI outcomes following such events.
Regional cerebral oxygen saturation (rSO 2 ) is a measure of cerebral perfusion that is obtained noninvasively via near-infrared spectroscopy and monitored in patients during cardiac arrest since the instrument does not require vascular pulsation. 10, 11 We previously reported that rSO 2 , measured upon arrival at the hospital, might help predict neurologic outcomes in patients following OHCA. 12 However, few studies have focused on whether rSO 2 measurements are effective for estimating brain damage severity, for determining prognoses, or in the decision-making process for PCAI in patients who have experienced OHCA of presumed cardiac cause. 13 Therefore, this study aimed to evaluate the clinical usefulness of rSO 2 monitoring to estimate the severity of brain damage and determine the prognoses of patients following OHCA of presumed cardiac causes.
Methods

Study design and setting
The Japan-Prediction of Neurological Outcomes in Patients Postcardiac Arrest (J-POP) Registry is a prospective multicentre cohort study, and 15 Japanese tertiary emergency care hospitals participated in the J-POP during the study period (15 May 2011 to 30 August 2013). The inclusion criterion was unresponsiveness during and after resuscitation upon arrival at the hospital following an OHCA. The exclusion criteria included (1) trauma, (2) accidental hypothermia, (3) age <18 years, (4) completion of the 'Do Not Attempt Resuscitation' form, and (5) a Glasgow coma scale (GCS) score >8 upon arrival at the hospital. The details of the J-POP registry design and main outcomes have been published elsewhere. 12 To identify the value of emergency room rSO 2 measurements in the PCAI (including TH and CAG) decision-making process, we analysed 1195 consecutive patients with OHCA of presumed cardiac cause from the J-POP registry.
Emergency medical care in Japan
In Japan, emergency lifesaving technicians are permitted to insert tracheal tubes and administer intravenous adrenaline (epinephrine). 14 All emergency medical service providers perform cardiopulmonary resuscitation (CPR) according to the current CPR guidelines. 15, 16 However, the providers are not permitted to terminate CPR in the field.
Procedures after arrival at the hospital
All patients received advanced life support in accordance with national guidelines. If sustained return of spontaneous circulation (ROSC), i.e. the restoration of a palpable pulse that is sustained for at least 20 min, was not obtained using standard advanced life support, patients with initially documented ventricular fibrillation or pulseless ventricular tachycardia received extracorporeal CPR and extracorporeal circulatory support or a cardiopulmonary bypass. If patients obtained sustained ROSC, TH was induced once their systolic blood pressure exceeded 90 mmHg and their GCS score was 3-8. 5, 17, 18 All procedural (e.g., extracorporeal CPR, CAG, PCI, and TH) and diagnostic decisions were made at the discretion of the attending physician(s).
Data collection
Data were prospectively collected according to the Utstein style. 19, 20 Baseline patient characteristics and in-hospital data were collected from medical records and databases.
Cardiac arrest was defined as the absence of spontaneous respiration, a palpable pulse, and stimuli responsiveness. 19 The arrest was presumed to be of cardiac origin unless it was due to cerebrovascular disease, respiratory disease, external factors (e.g., drug overdose or asphyxia), or other non-cardiac factors.
Near-infrared spectroscopy
Upon arrival at the hospital, 2 disposable near-infrared spectrometer (INVOS TM 5100C; Covidien, Boulder, CO, USA) probes were carefully applied to both sides of the patient's forehead. After several seconds of stabilisation, rSO 2 was monitored using the probes for at least 1 min, and the lowest rSO 2 reading was recorded. 11,12,21 
Study endpoints
The primary endpoint was the patients' 90-day neurologic outcomes, categorised according to the Glasgow-Pittsburgh cerebral performance categories (CPC), described in the Utstein style guidelines. 19 The guidelines categorise CPC 1 (good performance) and CPC 2 (moderate disability) as 'good neurologic outcomes', whereas CPC 3 (severe disability), CPC 4 (vegetative state), and CPC 5 (brain death or death) are defined as 'poor neurologic outcomes'. Individual patient CPC were determined by at least 2 physiciansin-charge who were blinded to the rSO 2 readings determined upon arrival at the hospital.
Statistical analyses
Unpaired t-tests or Mann-Whitney U-tests were conducted for unpaired comparisons. A 2 or Fischer's exact test was conducted to examine differences between categorical variables. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the accuracy of predicted post-event good neurologic outcomes at 90 days. To analyse the effects of rSO 2 on neurologic outcomes, we developed logistic regression models that were adjusted for a pulse detectable upon arrival at the hospital, defibrillation before arrival at the hospital, bystander-initiated CPR, age, male sex, use of an advanced airway device before arrival at the hospital, and intravenous epinephrine administration before arrival at the hospital, in addition to rSO 2 upon arrival at the hospital. The JMP (version 10.0.0, SAS Institute, Cary, NC, USA) and STATA (version 11.1, Stata, College Station, TX, USA) software were used for all statistical analyses. All reported probability values are 2-tailed, and P < 0.05 was considered statically significant.
Ethical considerations
This study complied with the Declaration of Helsinki and conformed to the Guidelines for Epidemiologic Studies issued by the Ministry of Health, Labour, and Welfare of Japan. The study protocol was approved by the institutional review board or ethics committee of each participating medical institution, which also waived the requirement for informed consent.
Results
General patient characteristics and outcomes
During the study period, the registry accumulated data on 3086 consecutive OHCA patients who were referred to the 15 participating hospitals. In accordance with the study protocol, 1921 consecutive patients were enrolled, and 1195 patients with OHCA of presumed cardiac cause were included in the analysis (Fig. 1) . Table 1 shows the characteristics and neurologic outcomes of all patients. Among all patients, 880 (74%) were pronounced dead in the emergency department. Of the remaining 315 patients, 223 (19%) died after admission to the hospital, whereas 92 (8%) survived for at least 90 days. After 90 days, 55 (5%), 13 (1%), 6 (0.5%), and 18 (2%) patients were classified as CPC 1, 2, 3, and 4, respectively. Accordingly, 68 patients (6%) were considered to have good neurologic outcomes (CPC 1 or 2). Patient characteristics and neurologic outcomes of all patients, patients with regional cerebral oxygen saturation ≥40%, and <40% upon arrival at the hospital.
Characteristics
All patients (n = 1195)
Patients with rSO2 <40% upon arrival at the hospital (n = 1092)
Patients with rSO2 ≥40% upon arrival at the hospital (n = 103) CPC, cerebral performance category; CPR, cardiopulmonary resuscitation; EMS, emergency medical service; PEA, pulseless electrical activity; rSO2, regional cerebral oxygen saturation; SD, standard deviation; VF, ventricular fibrillation; VT, ventricular tachycardia; OHCA, out-of-hospital cardiac arrest. * Comparing patients with rSO2 ≥40% and those with rSO2 <40% upon arrival at the hospital.
Regional cerebral oxygen saturation upon arrival at the hospital
We observed a mean (±standard deviation) rSO 2 of 21 ± 13% upon arrival at the hospital (Table 1) . According to the ROC curve analysis, the optimal cut-off for predicting good 90-day neurologic outcomes was an rSO 2 ≥40% (sensitivity 0.81, 95% confidence interval [CI] 0.70-0.89; specificity 0.96, 95% CI 0.94-0.97; area under the curve [AUC] 0.92, 95% CI 0.91-0.934; P < 0.001; Fig. 2) .
The characteristics and neurologic outcomes of patients with rSO 2 ≥40% (n = 103) and <40% (n = 1092) upon arrival at the hospital Fig. 2 . Receiver operating characteristic curve analysis of regional cerebral oxygen saturation upon arrival at the hospital as a predictor of good 90-day neurologic outcomes and neurologic outcomes according to regional cerebral oxygen saturation cut-off values. AUC, area under the curve; CI, confidence interval; CPC, Glasgow-Pittsburgh cerebral performance category; ROC, receiver operating characteristic; ROSC, return of spontaneous circulation; rSO2, regional cerebral oxygen saturation. Fig. 3 . Neurologic outcomes at 90 days, based on regional cerebral oxygen saturation cut-off values upon arrival at the hospital, in patients with an undetectable pulse or comatose patients with a detectable pulse upon arrival at the hospital, and in those undergoing or not undergoing therapeutic hypothermia and/or an emergent coronary angiography. (a) Neurologic outcomes (based on regional cerebral oxygen saturation cut-off values upon arrival at the hospital) in patients with an undetectable pulse or comatose patients with a detectable pulse upon arrival at the hospital; (b) neurologic outcomes at 90 days (based on regional cerebral oxygen saturation cut-off values upon arrival) at the hospital in patients undergoing or not undergoing therapeutic hypothermia and/or an emergent coronary angiography. CAG, coronary angiography, CPC, Glasgow-Pittsburgh cerebral performance category; OHCA, out-of-hospital cardiac arrest; rSO2, regional cerebral oxygen saturation; TH, therapeutic hypothermia.
are shown in Table 1 . Good neurologic outcomes were observed for 53% (55/103) and 1% (13/1092) of the patients with rSO 2 ≥40% and <40%, respectively (P < 0.001, Fig. 2 ).
Of the 89 comatose patients whose pulse could be detected upon arrival at the hospital, 73 had rSO 2 ≥40% and 16 had rSO 2 <40% (Fig. 3) . Among these patients, 46 (63%) patients with high rSO 2 measures had good neurologic outcomes. None of these patients had low rSO 2 (P < 0.001). Of the 1106 patients whose pulse could not be detected upon arrival at the hospital, 30 had rSO 2 ≥40% and 1076 had rSO 2 <40% (Fig. 3) . Among these patients, good neurologic outcomes were observed for 9 (30%) patients with high rSO 2 measures and 13 (1%) with low rSO 2 (P < 0.001).
Multivariate analyses for good neurologic outcomes
Multivariate analyses (adjusted for prehospital patient characteristics that showed a significant univariate association with outcomes) for good neurologic outcomes associated with prehospital variables and high (≥40%) rSO 2 indicated that high rSO 2 was independently associated with good neurologic outcomes (odds ratio 14.07, 95% CI 5.01-39.86, P < 0.001, AUC 0.96; Table 2 ).
Post-cardiac arrest interventions
Extracorporeal CPR, TH, CAG, and PCI were performed in 95 (8%), 154 (13%), 135 (11%), and 64 (5%) patients, respectively.
A higher proportion of patients who underwent TH had good neurologic outcomes (CPC1/2; 36%) than those not undergoing TH (CPC1/2; 1%, P < 0.001). Similarly, a higher proportion of patients who underwent a CAG had good neurologic outcomes (CPC1/2; 41%) than those who did not (CPC1/2; 1%, P < 0.001). Last, patients who underwent TH or a CAG showed significantly more favourable characteristics (Table 1) .
Furthermore, more than two thirds of patients with rSO 2 ≥40% who underwent TH or a CAG showed good neurologic outcomes (CPC1/2; 69%; Fig. 3 ), and this rate of good neurologic outcomes rate was significantly higher than in patients with rSO 2 <40% who underwent the same procedures (CPC1/2; 11%; P < 0.001). However, among patients with rSO 2 ≥40%, 24% (25/103) did not undergo TH or a CAG. These patients exhibited a significantly lower rate of good neurologic outcomes than those undergoing TH or a CAG (CPC1/2; 4% vs. 69%, respectively; P < 0.001; Fig. 3 ). Many of these patients had other unfavourable characteristics such as older age, OHCA at home, no witnesses, no bystander-initiated CPR, no Table 2 Multivariate analysis for good neurologic outcomes, adjusted for prehospital variables and regional cerebral oxygen saturation >40%. rSO2 ≥40% upon arrival at the hospital Good neurologic outcome 90 days after OHCA n/total n (%) n/total n (%) Odds ratio (not adjusted) CI, confidence interval; CPR, cardiopulmonary resuscitation; N/A, not applicable; OHCA, out-of-hospital cardiac arrest. * Adjusted for the following variables: pulse detectable at arrival at the hospital, defibrillation before arrival at the hospital, bystander-initiated CPR, age, male sex, use of advanced airway devices before arrival at the hospital, and intravenous adrenaline administration before arrival at the hospital.
Table 3
Characteristics of patients with high regional cerebral oxygen saturation (>40%) upon arrival at the hospital undergoing or not undergoing therapeutic hypothermia and/or an emergent coronary angiography.
Characteristics
Underwent therapeutic hypothermia and/or an emergent coronary angiography (n = 78)
Did not undergo therapeutic hypothermia and/or an emergent coronary angiography (n = 25) CPR, cardiopulmonary resuscitation; EMS, emergency medical service; OHCA, out-of-hospital cardiac arrest; PEA, pulseless electrical activity; rSO2, regional cerebral oxygen saturation; SD, standard deviation; VF, ventricular fibrillation; VT, ventricular tachycardia.
shockable rhythms, and no detectable pulse upon arrival at the hospital (Table 3) .
Discussion
Our results show that high rSO 2 upon arrival at the hospital predicted good 90-day neurologic outcomes with high sensitivity, specificity, and AUC (optimal cut-off, rSO 2 ≥40%) in patients experiencing OHCA of presumed cardiac cause. These data are consistent with our previous report on all non-trauma OHCA patients in the J-POP Registry. 12 Half of the patients (55/108, 51%) with rSO 2 ≥40% upon arrival at the hospital had good neurologic outcomes. Surprisingly, even if a pulse was not detectable upon arrival at the hospital, 30% of patients (9/30) with high rSO 2 demonstrated good neurologic outcomes. In contrast, none of the patients (0/19) with low rSO 2 had good neurologic outcomes, even if a pulse was detected upon arrival at the hospital. These compelling results show that rSO 2 monitoring is a promising method for selecting good candidates for PCAI (including TH, CAG, and PCI). To the best of our knowledge, this is the first report demonstrating the clinical usefulness of rSO 2 measurements for estimating brain damage severity and predicting outcomes in patients with OHCA of presumed cardiac origin.
As reported by Ito et al. 2/446 (0.4%) patients demonstrated good 90-day neurologic outcomes despite having low rSO 2 (15%) upon arrival at the hospital, implying that rSO 2 values alone cannot be used to determine whether resuscitative efforts should be terminated. Therefore, rSO 2 monitoring is useful for determining which patients will likely have good neurologic outcomes following OHCA of presumed cardiac cause (i.e. which patients are good PCAI candidates). 12 Many studies have shown strong positive effects of bundled PCAI for improving post-cardiac arrest outcomes. 1, 2, 22 Another multicentre registry study in Japan reported that 55% of OHCA patients had good neurologic prognoses after PCAI. 23 In the present study, up to 69% of patients with rSO 2 ≥40% showed good neurologic prognoses if they underwent PCAI. Thus, monitoring rSO 2 in the emergency room, following OHCA of presumed cardiac cause, provides a good indication of the 90-day neurologic outcomes following PCAI. However, in the present study, approximately 25% patients with high rSO 2 did not undergo TH or a CAG and these patients exhibited a significantly lower rate of good neurologic outcomes than those undergoing TH or a CAG (CPC1/2; 4% vs. 69%, respectively; P < 0.001; Fig. 3 ). High rSO 2 values upon hospital arrival indicated that the patients did not suffer from severe hypoxic cerebral damage. Thus, we hypothesised that rSO 2 was an intermediate factor in the process of cerebral damage formation after OHCA, and that high rSO 2 values upon hospital arrival indicated that the patients might be good candidates for PCAI even if they had unfavourable characteristics. In fact, as unfavourable characteristics were relatively common among these patients, PCAI might have been underutilised in these individuals. Further studies are needed to determine whether patients in this group are good candidates for PCAI.
TH at a target temperature of 33 • C was recently reported to not confer a benefit over TH at a target temperature of 36 • C, 6 implying the overuse of PCAI. Rittenberger et al. 24 remarked that future studies should continue to define patient subgroups that would benefit from specific therapies and clarify protocols for such interventions, based on each patient's illness, including a mandatory estimation of brain damage severity. Further studies are needed to clarify whether rSO 2 monitoring in the emergency room is useful for predicting brain damage severity and making decisions regarding PCAI administration.
This study has several limitations. Although we previously reported that continuous rSO 2 monitoring would be desirable prior to arrival at the hospital, the absence of portable near-infrared spectroscopy devices makes this impossible. 12 Second, near-infrared spectroscopy rSO 2 measurements reflect only cerebral perfusion in the superficial layers of limited frontal lobe areas, and rSO 2 is not a reliable marker of brain tissue oxygen partial pressure. [10] [11] [12] Third, we could not blind the investigators to the rSO 2 values because rSO 2 monitoring requires real-time visual confirmation. As per a pre-specified protocol, all patients received the best available therapy, regardless of their rSO 2 12 ; however, we could not eliminate the possibility that low rSO 2 might have influenced the decision to terminate resuscitation. Fourth, as emergency medical service providers in Japan are not permitted to terminate CPR, most OHCA patients who are treated by these personnel are transported to emergency departments. Thus, a very small proportion of patients with documented rhythms at the scene of cardiac arrest demonstrated ventricular tachycardia/fibrillation and had very poor 90-day neurologic outcomes. Hence, the international validity of this study might be limited. Finally, this study was not randomised, and to assess the predictive value of a clinical tool, precise validation cohorts are needed to verify our observations.
Conclusions
In conclusion, our study shows that rSO 2 ≥40% upon arrival at the hospital predicted good 90-day neurologic outcomes in patients suffering OHCA of presumed cardiac cause, even if a pulse was undetectable upon arrival at the hospital. Patients with rSO 2 ≥40% upon arrival at the hospital who underwent PCAI showed remarkably favourable neurologic prognoses. Thus, rSO 2 monitoring following OHCA of presumed cardiac cause is an indicator of 90-day neurologic outcomes following PCAI. However, about 25% of patients with rSO 2 ≥40% in our study did not undergo TH or a CAG and had quite poor neurologic outcomes, implying that PCAI might be underutilised in these cases. Future studies are necessary to evaluate the efficiency of rSO 2 monitoring during the PCAI decisionmaking process following OHCA of presumed cardiac cause.
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